MOB-015 is recommended for approval in EU: Moberg Pharma
/PRNewswire/ -- Moberg Pharma AB (OMX: MOB) hereby announces that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended...
Source: prnewswire.com
Stay updated with breaking news from Karen Hackney. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Moberg Pharma AB (OMX: MOB) hereby announces that the Decentralized Procedure has ended with a positive outcome and that MOB-015 is recommended...
Through IN-PART Discover, Bayer Consumer Health seeks academic partners for microbiome-targeting solutions for upper respiratory illnesses